Risk of adverse events with concomitant use of atorvastatin or simvastatin and glucose-lowering drugs (thiazolidinediones, metformin, sulfonylurea, insulin, and acarbose)
- PMID: 12031736
- DOI: 10.1016/s0002-9149(02)02334-2
Risk of adverse events with concomitant use of atorvastatin or simvastatin and glucose-lowering drugs (thiazolidinediones, metformin, sulfonylurea, insulin, and acarbose)
Comment in
-
Statin and adverse events: it does not add up.Am J Cardiol. 2003 Feb 1;91(3):383-4; author reply 384. doi: 10.1016/s0002-9149(02)03022-9. Am J Cardiol. 2003. PMID: 12565110 No abstract available.
Similar articles
-
Adverse events with concomitant use of simvastatin or atorvastatin and thiazolidinediones.Am J Cardiol. 2004 Jun 1;93(11):1417-8, A9. doi: 10.1016/j.amjcard.2004.02.045. Am J Cardiol. 2004. PMID: 15165929
-
Comparison of the frequency of adverse events in patients treated with atorvastatin or simvastatin.Am J Cardiol. 2003 Apr 15;91(8):999-1002, A7. doi: 10.1016/s0002-9149(03)00124-3. Am J Cardiol. 2003. PMID: 12686348 No abstract available.
-
Spontaneous reports cannot serve as a basis for comparison of two drugs.Am J Cardiol. 2003 Nov 1;92(9):1141-2. doi: 10.1016/j.amjcard.2003.06.015. Am J Cardiol. 2003. PMID: 14583380 No abstract available.
-
Peripheral neuropathy and lipid-lowering therapy.South Med J. 1998 Jul;91(7):667-8. doi: 10.1097/00007611-199807000-00013. South Med J. 1998. PMID: 9671841 Review.
-
[Interaction risk with statin switch].Tidsskr Nor Laegeforen. 2007 Feb 15;127(4):428-31. Tidsskr Nor Laegeforen. 2007. PMID: 17304269 Review. Norwegian.
Cited by
-
Drug Interactions of Clinical Importance with Antihyperglycaemic Agents : An Update.Drug Saf. 2005 Jul;28(7):601-631. doi: 10.2165/00002018-200528070-00004. Drug Saf. 2005. PMID: 27722966 Review.
-
A computerized system for detecting signals due to drug-drug interactions in spontaneous reporting systems.Br J Clin Pharmacol. 2010 Jan;69(1):67-73. doi: 10.1111/j.1365-2125.2009.03557.x. Br J Clin Pharmacol. 2010. PMID: 20078614 Free PMC article.
-
The development of combination drugs for atherosclerosis.Curr Atheroscler Rep. 2003 Jan;5(1):29-32. doi: 10.1007/s11883-003-0065-3. Curr Atheroscler Rep. 2003. PMID: 12562539 Review.
-
Pharmacokinetic interactions with thiazolidinediones.Clin Pharmacokinet. 2007;46(1):1-12. doi: 10.2165/00003088-200746010-00001. Clin Pharmacokinet. 2007. PMID: 17201456 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical